The Alethia C. difficile DNA amplification assay, performed on the Alethia reader, is a qualitative in-vitro diagnostic test for the direct detection of toxigenic C. difficile in human stool specimens from pediatric and adult patients suspected of having Clostridium difficile-associated disease (CDAD).

• Reduce the risk of missing a true positive with the accuracy of molecular

Fast, actionable results enable physicians to make informed decisions about the patient management and treatment resulting in reduced healthcare costs associated with isolation and antibiotics.